Angelini Ventures
Headquarter
Toronto, Ontario - Canada
Milestones
Founded: 2019
Invested: 2022
Founders / CEO
John Reilly, CEO
Vertical
Biotech
Board Participation
Thomas Thestrup, Board Member
Developer of biotechnology research platform intended to treat and prevent cognitive deficits across brain disorders and during aging. The company's platform offers small molecule therapeutics that transform the treatment of cognitive symptoms and restore normal life functions for underserved and understudied mental health and aging populations, enabling patients with the potential to reverse the impairment and in doing so resolve previously unresolvable symptoms.
Related news:
Spotlight Story DAMONA. Pharmaceuticals is Shaping a New Path for Cognitive Care